Fulcrum to assess muscle disorder drug losmapimod for Covid-19
The trial will enrol about 400 adults hospitalised due to Covid-19. Credit: HFCM Communicatie.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
